TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
IMTX

Immatics NV

Healthcare · Biotechnology

8.50$ +1.6% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement IMTX
Line item 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
901.1% 217.3% 214.7% 251.9% 61.8% 219.8% 95.0% –
-801.1% -117.3% -114.7% 100.0% 100.0% 100.0% 100.0% 100.0%
901.1% 217.3% 214.7% 251.9% 61.8% 219.8% 95.0% 380.9%
203.3% 63.7% 109.2% 97.3% 20.9% 70.7% 29.8% 106.0%
1,012.7% 278.9% 108.4% 348.2% 82.7% 288.4% 124.8% 477.1%
-912.7% -178.9% -223.1% -248.2% 17.3% -188.4% -24.8% -377.1%
0.4% 0.9% 0.9% 1.6% 0.6% 1.5% 0.6% 2.0%
-858.2% -176.1% -677.8% -268.5% 24.3% -179.6% 13.7% -411.1%
-78.6% -4.0% -0.9% 5.0% 8.3% -4.3% 3.9% -4.1%
-834.1% -172.0% -676.0% -268.5% 16.0% -175.3% 9.8% -407.0%
-841.5% -154.3% -215.9% -251.7% 29.0% -164.7% 22.1% -383.5%

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?